Cost-effectiveness study on the provox®2 and the Groningen ultra low resistance tracheoesophageal shunt prostheses

ISRCTN ISRCTN31438086
DOI https://doi.org/10.1186/ISRCTN31438086
Secondary identifying numbers ABR NL12933.042.06, NL777, NTR788
Submission date
28/12/2006
Registration date
28/12/2006
Last edited
06/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr K Harms
Scientific

University Medical Center Groningen (UMCG)
Deparment of ENT
P.O. Box 30001
Groningen
9700 RB
Netherlands

Study information

Study designProspective randomised, controlled, crossover group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleCost-effectiveness study on the provox®2 and the Groningen ultra low resistance tracheoesophageal shunt prostheses
Study objectivesHypothesis 1: the Groningen Ultra Low Resistance (ULR) and the Provox®2 are the same in terms of the replacement method, the burden on the patient and the convenience of the replacement and of the resistance during phonation.
Hypothesis 2: the Groningen ULR has a longer lifetime than the Provox®2 and is thus less expensive in use.
Hypothesis 3: the quality of life of the patient is higher while using the Groningen ULR than when using the Provox®2.
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedTracheoesophageal shunt prostheses following laryngectomy
InterventionProspective randomised cross-over design with a group of 80 patients aged 45 to 70 out of our population of over 134 post laryngectomy patients that have been using a TracheoEsophageal Shunt Prostheses (TESP) for their phonation for at least six months. The patients are randomly divided into four groups according to the following schedule:

Group 1, 20 persons: G-G-G
Group 2, 20 persons: G-G-P
Group 3, 20 persons: P-P-G
Group 4, 20 persons: P-P-P

G= Groningen ultra low resistance
P= Provox®2
Intervention typeOther
Primary outcome measureLifetime of both types of TE shunt prosthesis
Secondary outcome measures1. Total costs for the use of both the Provox®2 and Groningen ULR TE shunt prostheses. An incremental cost analysis.
2. Quality of life.
3. Evaluation of both types of prostheses.
4. Preference of patients for one of both types of prostheses.
5. Experience with replacement and -technique.
6. Diet: Food products that influence lifetime of the TE shunt prosthesis.
7. Expenses made by patient.
Overall study start date01/11/2006
Completion date10/04/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants80
Total final enrolment80
Key inclusion criteriaPatients from our outpatient clinic (Ear, Nose and Throat [ENT] Department at University Medical Centre Groningen [UMCG]): post-laryngectomees that use a TracheoEsophageal (TE) shunt prosthesis for their phonation.
Key exclusion criteria1. Patients younger than 45 or older than 70
2. Patients that have a metastasis or recurrence of their previous larynx carcinoma
3. Patients that smoke tobacco
Date of first enrolment01/11/2006
Date of final enrolment10/04/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center Groningen (UMCG)
Groningen
9700 RB
Netherlands

Sponsor information

University Medical Center Groningen (UMCG) (The Netherlands)
Hospital/treatment centre

c/o Dr. B. van der Laan
Head of Department of Ear, Nose and Throat Medicine
P.O. Box 30001
Groningen
9700 RB
Netherlands

Website http://www.rug.nl/umcg/index?lang=en
ROR logo "ROR" https://ror.org/03cv38k47

Funders

Funder type

Not defined

Not provided at time of registration

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2011 06/01/2021 Yes No

Editorial Notes

06/01/2021: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
3. The NTR numbers have been added.